Literature DB >> 11453728

Elucidation of reaction scheme describing malondialdehyde-acetaldehyde-protein adduct formation.

D J Tuma1, M L Kearley, G M Thiele, S Worrall, A Haver, L W Klassen, M F Sorrell.   

Abstract

Malondialdehyde and acetaldehyde react together with proteins and form hybrid protein conjugates designated as MAA adducts, which have been detected in livers of ethanol-fed animals. Our previous studies have shown that MAA adducts are comprised of two distinct products. One adduct is composed of two molecules of malondialdehyde and one molecule of acetaldehyde and was identified as the 4-methyl-1,4-dihydropyridine-3,5-dicarbaldehyde derivative of an amino group (MDHDC adduct). The other adduct is a 1:1 adduct of malondialdehyde and acetaldehyde and was identified as the 2-formyl-3-(alkylamino)butanal derivative of an amino group (FAAB adduct). In this study, information on the mechanism of MAA adduct formation was obtained, focusing on whether the FAAB adduct serves as a precursor for the MDHDC adduct. Upon the basis of chemical analysis and NMR spectroscopy, two initial reaction steps appear to be a prerequisite for MDHDC formation. One step involves the reaction of one molecule of malondialdehyde and one of acetaldehyde with an amino group of a protein to form the FAAB product, while the other step involves the generation of a malondialdehyde-enamine. It appears that generation of the MDHDC adduct requires the FAAB moiety to be transferred to the nitrogen of the MDA-enamine. For efficient reaction of FAAB with the enamine to take place, additional experiments indicated that these two intermediates likely must be in positions on the protein of close proximity to each other. Further studies showed that the incubation of liver proteins from ethanol-fed rats with MDA resulted in a marked generation of MDHDC adducts, indicating the presence of a pool of FAAB adducts in the liver of ethanol-fed animals. Overall, these findings show that MDHDC-protein adduct formation occurs via the reaction of the FAAB moiety with a malondialdehyde-enamine, and further suggest that a similar mechanism may be operative in vivo in the liver during prolonged ethanol consumption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453728     DOI: 10.1021/tx000222a

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  18 in total

1.  Malondialdehyde-acetaldehyde-adducted protein inhalation causes lung injury.

Authors:  Todd A Wyatt; Kusum K Kharbanda; Michael L McCaskill; Dean J Tuma; Daniel Yanov; Jane DeVasure; Joseph H Sisson
Journal:  Alcohol       Date:  2011-09-29       Impact factor: 2.405

2.  Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint.

Authors:  Ted R Mikuls; Michael J Duryee; Rafid Rahman; Daniel R Anderson; Harlan R Sayles; Andrew Hollins; Kaleb Michaud; Frederick Wolfe; Geoffrey E Thiele; Jeremy Sokolove; William H Robinson; Nithya Lingampalli; Anthony P Nicholas; Geoffrey A Talmon; Kaihong Su; Matthew C Zimmerman; Lynell W Klassen; Geoffrey M Thiele
Journal:  Rheumatology (Oxford)       Date:  2017-10-01       Impact factor: 7.580

3.  New Evidence for the Diversity of Mechanisms and Protonated Schiff Bases Formed in the Non-Enzymatic Covalent Protein Modification (NECPM) of HbA by the Hydrate and Aldehydic Forms of Acetaldehyde and Glyceraldehyde.

Authors:  Justin Lewis; Brandy A Smith; Heaton Oakes; R W Holman; Kenneth J Rodnick
Journal:  Cogent Biol       Date:  2019-02-20

4.  Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.

Authors:  Ayelet Gonen; Lotte F Hansen; William W Turner; Erica N Montano; Xuchu Que; Apaїs Rafia; Meng-Yun Chou; Philipp Wiesner; Dimitrios Tsiantoulas; Maripat Corr; Michael S VanNieuwenhze; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum; Karsten Hartvigsen
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

Review 5.  Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.

Authors:  Bryant R England; Geoffrey M Thiele; Daniel R Anderson; Ted R Mikuls
Journal:  BMJ       Date:  2018-04-23

6.  Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.

Authors:  Geoffrey M Thiele; Michael J Duryee; Daniel R Anderson; Lynell W Klassen; Stephen M Mohring; Kathleen A Young; Dathe Benissan-Messan; Harlan Sayles; Anand Dusad; Carlos D Hunter; Jeremy Sokolove; William H Robinson; James R O'Dell; Anthony P Nicholas; Dean J Tuma; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

7.  Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.

Authors:  Geoffrey M Thiele; Michael J Duryee; Carlos D Hunter; Bryant R England; Benjamin S Fletcher; Eric C Daubach; Taylor P Pospisil; Lynell W Klassen; Ted R Mikuls
Journal:  Int Immunopharmacol       Date:  2020-03-27       Impact factor: 4.932

8.  Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts.

Authors:  Outi Kummu; S Pauliina Turunen; Piotr Prus; Jaakko Lehtimäki; Marja Veneskoski; Chunguang Wang; Sohvi Hörkkö
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

9.  Malondialdehyde-acetaldehyde (MAA) adducted proteins bind to scavenger receptor A in airway epithelial cells.

Authors:  John P Berger; Samantha M Simet; Jane M DeVasure; Jessica A Boten; Jenea M Sweeter; Kusum K Kharbanda; Joseph H Sisson; Todd A Wyatt
Journal:  Alcohol       Date:  2014-05-11       Impact factor: 2.405

Review 10.  Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis.

Authors:  N Papac-Milicevic; C J-L Busch; C J Binder
Journal:  Adv Immunol       Date:  2016-04-05       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.